独立行政法人国立病院機構南京都病院は、京都府城陽市にある医療機関。独立行政法人国立病院機構が運営する病院である。旧国立療養所南京都病院。政策医療分野における神経・筋疾患、呼吸器疾患、重症心身障害、長寿医療、成育医療の専門医療施設である。

During the past decade, National Hospital Organization Minami-Kyoto Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Minami-Kyoto Hospital" are "Alzheimer Disease" (3 trials). Many other conditions were trialed in "National Hospital Organization Minami-Kyoto Hospital" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Minami-Kyoto Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "bapineuzumab" (2 trials), "placebo" (2 trials) and "Bapineuzumab 0.5 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Minami-Kyoto Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Minami-Kyoto Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Hospital Organization Minami-Kyoto Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Minami-Kyoto Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".